Showing results (1-10 of 351) with videos related to
Sort By:
Pageof 36
Clinical Lymphoma|October 23, 2004
Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyondAndrew M Evens, Leo I GordonCurrent Treatment Options in Oncology|June 21, 2002
Burkitt's and Burkitt-like lymphomaAndrew M Evens, Leo I GordonCurrent Treatment Options in Oncology|June 22, 2005
Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignanciesAndrew M Evens, Lakshmi Balasubramanian, Leo I GordonLeukemia & Lymphoma|May 18, 2010
Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applicationsSairah Ahmed, Jane N Winter, Leo I Gordon, et al.Anticancer Research|June 10, 2010
Motexafin gadolinium enhances p53-Mdm2 interactions, reducing p53 and downstream targets in lymphoma cell linesAmareshwar T K Singh, Andrew M Evens, Sheila N Prachand, et al.Plos One|December 7, 2013
Paradoxical regulation of hypoxia inducible factor-1α (HIF-1α) by histone deacetylase inhibitor in diffuse large B-cell lymphomaSavita Bhalla, Andrew M Evens, Sheila Prachand, et al.Current Oncology Reports|October 22, 2010
Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapyAndrew M Evens, Rupali Roy, Danielle Sterrenberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependentAndrew M Evens, Sheila Prachand, Bo Shi, et al.Clinical Lymphoma & Myeloma|September 19, 2007
Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphomaAndrew M Evens, Sheryl L Ziegler, Rohit Gupta, et al.Blood|June 2, 2011
The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphomaSavita Bhalla, Andrew M Evens, Bojie Dai, et al.Pageof 36